DHFR-IN-8 is a dihydrofolate reductase (DHFR) inhibitor that interferes with the biosynthesis of purines and thymidylate, thereby affecting cell proliferation and growth; it exhibits anti-infective activity against methicillin-resistant Staphylococcus aureus (MRSA) ATCC 43300 (IC50 = 15.6 ng/mL) in murine models of systemic and thigh infections at a dose of 60 mg/kg (intraperitoneal).